Welcome to LookChem.com Sign In|Join Free
  • or
3-fluoro-4-(methylsulfonylmethyl)phenol is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1037776-17-2

Post Buying Request

1037776-17-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1037776-17-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1037776-17-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,7,7,7 and 6 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1037776-17:
(9*1)+(8*0)+(7*3)+(6*7)+(5*7)+(4*7)+(3*6)+(2*1)+(1*7)=162
162 % 10 = 2
So 1037776-17-2 is a valid CAS Registry Number.

1037776-17-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-fluoro-4-(methylsulfonylmethyl)phenol

1.2 Other means of identification

Product number -
Other names 3-fluoro-4-methanesulfonylmethylphenol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1037776-17-2 SDS

1037776-17-2Relevant academic research and scientific papers

SUBSTITUTED PIPERIDINE DERIVATIVES AND METHODS FOR PREPARING THE SAME

-

Paragraph 122; 123; 124; 125; 126, (2013/07/25)

The present invention relates to a novel compound or a pharmaceutically acceptable salt thereof, a preparation method thereof and a pharmaceutical composition for treating metabolism-related disorder containing the same. Specifically, the present invention relates to a compound of the formula 1, which can activate GPR119 to treat metabolism-related disorders, including diabetes and related diseases, diabetes-related microvascular complications, diabetes-related macrovascular complications, cardiovascular abnormalities, metabolic syndrome and its constituent diseases, and obesity.

PIPERIDINE GPCR AGONISTS

-

Page/Page column 12-13, (2008/12/07)

Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1037776-17-2